AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23675549 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (ivermectin/albendazole with azithromycin 1 week later)
Number of subjects: 3011
Study 20653804 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including toileting assistance, exercise, and choice of food and fluid snacks every 2 hours for 8 hours per day over 3 months
Number of subjects: 112
Study 20653804 — intervention group
Group type: EXPERIMENTAL
Intervention: Anorectal assessments on a subset of 29 residents
Number of subjects: 112
Study 17661038 — intervention group
Group type: EXPERIMENTAL
Intervention: Glufosfamide 4,500 mg/m(2) + Gemcitabine 1,000 mg/m(2)
Number of subjects: 19
Study 16768197 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam
Number of subjects: 86
Study 16768197 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 86
Study 16768197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 12936918 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fish oil (0.3, 1, and 2 g eicosapentaenoic acid plus docosahexaenoic acid/d for 4 consecutive weeks)
Number of subjects: 16
Study 12936918 — intervention group
Group type: COMPARATOR
Intervention: Antioxidant cosupplementation (200 microg Se, 3 mg Mn, 30 mg RRR‐alpha‐tocopheryl succinate, 90 mg ascorbic acid, 450 microg vitamin A)
Number of subjects: 16
Study 12936918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 10795943 — intervention group
Group type: EXPERIMENTAL
Intervention: DWI Education
Number of subjects: 246
Study 10795943 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping Skills
Number of subjects: 246
Study 10795943 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactional
Number of subjects: 246
Study 10795943 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 246
Study 9106811 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sodium amytal (SA)
Number of subjects: 17
Study 9106811 — intervention group
Group type: EXPERIMENTAL
Intervention: Sympathetic blocks and A-fibre ischemic blocks
Number of subjects: 17
Study 9106811 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal stimulation
Number of subjects: 17
Study 8441761 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril 2.5 mg
Number of subjects: 33
Study 3763944 — intervention group
Group type: EXPERIMENTAL
Intervention: BN 52063 (PAF antagonist) at a dose of 80 mg
Number of subjects: 0
Study 3763944 — intervention group
Group type: EXPERIMENTAL
Intervention: BN 52063 (PAF antagonist) at doses of 20, 40, 80, and 120 mg
Number of subjects: 0
Study 3763944 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 29735455 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mL of 0.2% ropivacaine injection at acupoints Hegu and Sanyinjiao
Number of subjects: 120
Study 29735455 — intervention group
Group type: COMPARATOR
Intervention: Normal saline injection at acupoints Hegu and Sanyinjiao
Number of subjects: 120
Study 28393815 — intervention group
Group type: EXPERIMENTAL
Intervention: Centric stabilization splint (CSS)
Number of subjects: 30
Study 28393815 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft splint (SS)
Number of subjects: 30
Study 28393815 — intervention group
Group type: COMPARATOR
Intervention: Conventional anterior repositioning appliance (ARA)
Number of subjects: 30
Study 24164308 — intervention group
Group type: EXPERIMENTAL
Intervention: UVA1 treatment (medium-dose, four times weekly for 3 months)
Number of subjects: 10
Study 21785863 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 50 mg/kg clofibrate and phototherapy
Number of subjects: 60
Study 21785863 — intervention group
Group type: COMPARATOR
Intervention: Phototherapy alone
Number of subjects: 60
Study 20090398 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 150
Study 20090398 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 150
Study 18773732 — intervention group
Group type: EXPERIMENTAL
Intervention: Images with high Fourier amplitude at spatial frequencies within two octaves of 3 cycles deg(‐1)
Number of subjects: 6
Study 18773732 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex images with altered phase or amplitude spectra
Number of subjects: 6
Study 18773732 — intervention group
Group type: EXPERIMENTAL
Intervention: Art images that have received negative public reaction
Number of subjects: 6
Study 15634716 — intervention group
Group type: EXPERIMENTAL
Intervention: NETE 200 mg plus TU 1000 mg every 8 wk
Number of subjects: 50
Study 15634716 — intervention group
Group type: COMPARATOR
Intervention: NETE 200 mg plus TU 1000 mg every 12 wk
Number of subjects: 50
Study 15634716 — intervention group
Group type: COMPARATOR
Intervention: TU 1000 mg plus placebo every 12 wk
Number of subjects: 50
Study 15634716 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus placebo every 6 wk for 12 wk and then every 12 wk
Number of subjects: 50
Study 12783372 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 1106
Study 12783372 — intervention group
Group type: COMPARATOR
Intervention: IFN/LDAC
Number of subjects: 1106
Study 10655919 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 24
Study 10655919 — intervention group
Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 24
Study 8889345 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoprostenol (Flolan)
Number of subjects: 0
Study 8889345 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic assessment
Number of subjects: 0
Study 1400881 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRP 1 microgram/kg body weight
Number of subjects: 5
Study 1400881 — intervention group
Group type: COMPARATOR
Intervention: GHRH 1 microgram/kg body weight
Number of subjects: 5
Study 1400881 — intervention group
Group type: COMPARATOR
Intervention: Saline (sal)
Number of subjects: 5
Study 4073878 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline hydrochloride at 0.5 g every 6 h or doxycycline at 100 mg every 12 h for 30 days plus 1 g of streptomycin a day for 21 days (Group A)
Number of subjects: 46
Study 4073878 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin at 15 mg/kg per day in a single morning dose plus 100 mg of doxycycline every 12 h for 30 days (Group B)
Number of subjects: 46
Study 31737351 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) delivered in 2 face-to-face sessions and 4 phone sessions
Number of subjects: 65
Study 31737351 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 65
Study 29485323 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-ingredient dietary preworkout supplement
Number of subjects: 12
Study 29485323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 26659069 — intervention group
Group type: EXPERIMENTAL
Intervention: TDF-FTC
Number of subjects: 160
Study 26659069 — intervention group
Group type: COMPARATOR
Intervention: Non-TDF-FTC
Number of subjects: 160
Study 25283252 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g/day of oral collagen peptide (CP) for 4 weeks
Number of subjects: 8
Study 25283252 — intervention group
Group type: COMPARATOR
Intervention: Control group (no collagen peptide)
Number of subjects: 8
Study 22484523 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mL of alcohol-free wine
Number of subjects: 0
Study 22484523 — intervention group
Group type: COMPARATOR
Intervention: Low phenolic diet (LPD)
Number of subjects: 0
Study 20418184 — intervention group
Group type: EXPERIMENTAL
Intervention: Raw ginger (2 grams for 11 days)
Number of subjects: 74
Study 20418184 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-treated ginger (2 grams for 11 days)
Number of subjects: 74
Study 20418184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 17823302 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking interval training on treadmill with 40% body weight unloading (BWU) for 12 weeks
Number of subjects: 22
Study 17823302 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention control group
Number of subjects: 22
Study 15949594 — intervention group
Group type: EXPERIMENTAL
Intervention: PVU group (2 courses of cisplatin 80 mg/m2, i.v. x 1 (day 1), vindesine 3 mg/m2, i.v. x 1 (days 1 and 8) and UFT 400 mg/day, p.o. for 2 years)
Number of subjects: 150
Study 15949594 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT group (UFT 400 mg/day, p.o. for 2 years)
Number of subjects: 150
Study 15949594 — intervention group
Group type: COMPARATOR
Intervention: Control group (surgery alone)
Number of subjects: 150
Study 15949594 — intervention group
Group type: EXPERIMENTAL
Intervention: PVU group
Number of subjects: 150
Study 15949594 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 12446366 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased erythrocyte aldose reductase (AR) levels in NIDDM patients with diabetes duration of less than 10 years
Number of subjects: 611
Study 12446366 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased erythrocyte aldose reductase (AR) levels in NIDDM patients with diabetes duration of 10-20 years
Number of subjects: 611
Study 12446366 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased erythrocyte aldose reductase (AR) levels in NIDDM patients with diabetes duration of 20 years or more
Number of subjects: 611
Study 10354259 — intervention group
Group type: EXPERIMENTAL
Intervention: Two workshops on physical activity counseling
Number of subjects: 48
Study 10354259 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 48
Study 8526170 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisia extract
Number of subjects: 25
Study 8526170 — intervention group
Group type: COMPARATOR
Intervention: Betula or Phleum extracts
Number of subjects: 25
Study 1951004 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 17
Study 1951004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 6613461 — intervention group
Group type: EXPERIMENTAL
Intervention: neurolept anaesthesia combined with thoracic epidural analgesia
Number of subjects: 45
Study 6613461 — intervention group
Group type: COMPARATOR
Intervention: neurolept anaesthesia
Number of subjects: 45
Study 31829286 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of a Fitbit-compatible web app, group education, individual counselling by a physiotherapist, and six phone calls with a physiotherapist.
Number of subjects: 134
Study 31829286 — intervention group
Group type: COMPARATOR
Intervention: Delayed control group (6 months later).
Number of subjects: 134
Study 29576395 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent chlorhexidine-impregnated dressing with skin-protective acrylic terpolymer barrier film (3M™ Cavilon™ No - Sting Barrier Film)
Number of subjects: 60
Study 29576395 — intervention group
Group type: COMPARATOR
Intervention: Standard transparent catheter dressings without the skin-protecting barrier film
Number of subjects: 60
Study 29576395 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention and control groups
Number of subjects: 60
Study 27524522 — intervention group
Group type: EXPERIMENTAL
Intervention: Density gradient method
Number of subjects: 220
Study 27524522 — intervention group
Group type: COMPARATOR
Intervention: Swim-up method
Number of subjects: 220
Study 27524522 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 220
Study 24672814 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol plus NAC
Number of subjects: 0
Study 24672814 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 0
Study 24672814 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol
Number of subjects: 0
Study 22135319 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial Preference Pacing (APP) ON
Number of subjects: 40
Study 22135319 — intervention group
Group type: COMPARATOR
Intervention: Atrial Preference Pacing (APP) OFF
Number of subjects: 40
Study 19841931 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Number of subjects: 16
Study 19841931 — intervention group
Group type: COMPARATOR
Intervention: Sham IMT placebo control
Number of subjects: 16
Study 17272966 — intervention group
Group type: EXPERIMENTAL
Intervention: CHF 1512
Number of subjects: 74
Study 17272966 — intervention group
Group type: COMPARATOR
Intervention: LD/CD
Number of subjects: 74
Study 15599128 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral interventions
Number of subjects: 171
Study 12172327 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 98
Study 12172327 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 98
Study 12172327 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 98
Study 12172327 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa
Number of subjects: 98
Study 12172327 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 98
Study 12172327 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 98
Study 12172327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 10458542 — intervention group
Group type: EXPERIMENTAL
Intervention: Lentinan (2 mg) administered 7 days before surgery
Number of subjects: 25
Study 10458542 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 patients)
Number of subjects: 25
Study 7791055 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ketorolac (Acular)
Number of subjects: 140
Study 7791055 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diclofenac (Voltaren)
Number of subjects: 140
Study 7791055 — intervention group
Group type: COMPARATOR
Intervention: Control medication (HypoTears)
Number of subjects: 140
Study 7791055 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acetaminophen #3
Number of subjects: 140
Study 2225696 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (2.7 gm/day)
Number of subjects: 8
Study 2225696 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 389351 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin 3 g
Number of subjects: 160
Study 389351 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin 3 g plus probenecid 1 g
Number of subjects: 160
Study 30922317 — intervention group
Group type: EXPERIMENTAL
Intervention: artemether-lumefantrine (AL)
Number of subjects: 3127
Study 30922317 — intervention group
Group type: EXPERIMENTAL
Intervention: amodiaquine-artesunate (ASAQ)
Number of subjects: 3127
Study 30922317 — intervention group
Group type: EXPERIMENTAL
Intervention: mefloquine-artesunate (MQAS)
Number of subjects: 3127
Study 30922317 — intervention group
Group type: EXPERIMENTAL
Intervention: dihydroartemisinin-piperaquine (DHA-PQ)
Number of subjects: 3127
Study 29289942 — intervention group
Group type: EXPERIMENTAL
Intervention: High quality care (38% of patients)
Number of subjects: 1724
Study 29289942 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate quality care (11% of patients)
Number of subjects: 1724
Study 29289942 — intervention group
Group type: EXPERIMENTAL
Intervention: Low quality care (17% of patients)
Number of subjects: 1724
Study 29289942 — intervention group
Group type: EXPERIMENTAL
Intervention: No quality care (35% of patients)
Number of subjects: 1724
Study 24532801 — intervention group
Group type: EXPERIMENTAL
Intervention: Social-skills training and parental training plus standard treatment
Number of subjects: 47
Study 24532801 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 47
Study 23494184 — intervention group
Group type: EXPERIMENTAL
Intervention: SERI
Number of subjects: 20
Study 23494184 — intervention group
Group type: COMPARATOR
Intervention: Scarf
Number of subjects: 20
Study 20930708 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening ingestion of ACE inhibitors (benazepril, captopril, enalapril, lisinopril, perindopril, quinapril, ramipril, spirapril, trandolapril)
Number of subjects: 0
Study 20930708 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening ingestion of ARBs (irbesartan, olmesartan, telmisartan, valsartan)
Number of subjects: 0
Study 20930708 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronotherapy (timing of treatment to body rhythms)
Number of subjects: 0
Study 19344560 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefalotin
Number of subjects: 126
Study 19344560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 16948837 — intervention group
Group type: EXPERIMENTAL
Intervention: Bagged larvae
Number of subjects: 35
Study 16948837 — intervention group
Group type: EXPERIMENTAL
Intervention: Loose larvae
Number of subjects: 35
Study 16948837 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (hydrogel)
Number of subjects: 35
Study 15107659 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (n=5)
Number of subjects: 12
Study 15107659 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=7)
Number of subjects: 12
Study 11682388 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS-Titrated group (n = 32)
Number of subjects: 62
Study 11682388 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 62
Study 11682388 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study 9167508 — intervention group
Group type: EXPERIMENTAL
Intervention: Subanesthetic doses of ketamine
Number of subjects: 17
Study 7948468 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose ingestion (100 mg)
Number of subjects: 0
Study 7948468 — intervention group
Group type: COMPARATOR
Intervention: Water ingestion
Number of subjects: 0
Study 2893080 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 25 mg thrice a day
Number of subjects: 60
Study 2893080 — intervention group
Group type: COMPARATOR
Intervention: Frusemide 40 mg daily
Number of subjects: 60
Study 2893080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 28279123 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clarithromycin (7.5 mg/kg, twice a day)
Number of subjects: 40
Study 28279123 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 40
Study 28538060 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy
Number of subjects: 20
Study 28538060 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 26958294 — intervention group
Group type: EXPERIMENTAL
Intervention: Image-based dietitian support
Number of subjects: 0
Study 26958294 — intervention group
Group type: COMPARATOR
Intervention: Peer support
Number of subjects: 0
Study 26958294 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-based visual diary
Number of subjects: 0
Study 24334921 — intervention group
Group type: EXPERIMENTAL
Intervention: Type I diet (low in carbohydrates)
Number of subjects: 280
Study 24334921 — intervention group
Group type: EXPERIMENTAL
Intervention: Type II diet (low in fats)
Number of subjects: 280
Study 24334921 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 280
Study 21142464 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar spinous process-splitting laminectomy (LSPSL)
Number of subjects: 41
Study 18942898 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg bolus of pantoprazole followed by continuous infusion of 8 mg/h for 72 hours (group 0)
Number of subjects: 41
Study 18942898 — intervention group
Group type: COMPARATOR
Intervention: 40 mg of pantoprazole administered intravenously daily (group 1)
Number of subjects: 41
Study 17275361 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression plus superficial venous surgery
Number of subjects: 500
Study 17275361 — intervention group
Group type: COMPARATOR
Intervention: Multilayer compression
Number of subjects: 500
Study 15356822 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin and Pyrazinamide (RZ)
Number of subjects: 1466
Study 15356822 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid (INH)
Number of subjects: 1466
Study 11297719 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS for 4 weeks
Number of subjects: 18
Study 11297719 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 18
Study 9386661 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive expiratory pressure (PEP) technique with a PEP mask (Astra Meditec)
Number of subjects: 40
Study 9386661 — intervention group
Group type: COMPARATOR
Intervention: Conventional postural drainage and percussion (PD&P)
Number of subjects: 40
Study 8131199 — intervention group
Group type: EXPERIMENTAL
Intervention: Soap enema
Number of subjects: 200
Study 8131199 — intervention group
Group type: COMPARATOR
Intervention: No enema (control)
Number of subjects: 200
Study 2445316 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide (200 to 400 mg per day)
Number of subjects: 81
Study 2445316 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone (800 to 400 mg per day)
Number of subjects: 81
Study 29136550 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cerebellar transcranial direct current stimulation (ctDCS), 1 mA, 20 min (N=14)
Number of subjects: 28
Study 29136550 — intervention group
Group type: COMPARATOR
Intervention: Sham cerebellar transcranial direct current stimulation (sham-ctDCS) (N=14)
Number of subjects: 28
Study 27546353 — intervention group
Group type: EXPERIMENTAL
Intervention: Real time myocardial perfusion echocardiography (RT‐MPE)
Number of subjects: 27
Study 27546353 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac magnetic resonance (CMR)
Number of subjects: 27
Study 27546353 — intervention group
Group type: EXPERIMENTAL
Intervention: Infarct mass
Number of subjects: 27
Study 27546353 — intervention group
Group type: EXPERIMENTAL
Intervention: Myocardial blood flow (MBF)
Number of subjects: 27
Study 24780069 — intervention group
Group type: EXPERIMENTAL
Intervention: ZNF259 rs2075290, ZNF259 rs964184 and BUD13 rs10790162 SNPs
Number of subjects: 1181
Study 24780069 — intervention group
Group type: EXPERIMENTAL
Intervention: BUD13 rs10790162
Number of subjects: 1181
Study 24780069 — intervention group
Group type: EXPERIMENTAL
Intervention: G-G-A-A-C-C haplotype (carrying rs964184-G-allele)
Number of subjects: 1181
Study 24780069 — intervention group
Group type: EXPERIMENTAL
Intervention: A-C-G-G-C-C haplotype (carrying rs964184-C-allele)
Number of subjects: 1181